Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,110

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

March 31, 2013

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

sargramostim

BIOLOGICAL

telomerase peptide vaccine GV1001

DRUG

capecitabine

DRUG

gemcitabine hydrochloride

Trial Locations (45)

EX31 4JB

North Devon District Hospital, Barnstaple

RG24 9NA

Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke

PE21 9QT

Pilgrim Hospital, Boston

BH7 7DW

Royal Bournemouth Hospital, Bournemouth

BN2 5BE

Sussex Cancer Centre at Royal Sussex County Hospital, Brighton

BS2 8ED

Bristol Haematology and Oncology Centre, Bristol

CB2 0QQ

Addenbrooke's Hospital, Cambridge

DA2 8DA

Darent Valley Hospital, Dartford Kent

DT1 2JY

Dorset County Hospital, Dorchester

EX2 5DW

Royal Devon and Exeter Hospital, Exeter

GU2 7XX

St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford

HD3 3EA

Huddersfield Royal Infirmary, Huddersfield, West Yorks

IP4 5PD

Ipswich Hospital, Ipswich

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

L7 8XP

Royal Liverpool University Hospital, Liverpool

EC1A 7BE

Saint Bartholomew's Hospital, London

SE5 9NU

Cancer Research UK Clinical Groups at Guy's King's & St. Thomas' Hospitals, London

SW17 0QT

St. George's Hospital, London

SW3 6JJ

Royal Marsden - London, London

M20 4BX

Christie Hospital, Manchester

CH63 4JY

Clatterbridge Centre for Oncology, Merseyside

TS4 3BW

James Cook University Hospital, Middlesbrough

NE4 6BE

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

NR31 6LA

James Paget Hospital, Norfolk

HA6 2RN

Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

NG5 1PB

Nottingham City Hospital, Nottingham

OX3 7LJ

Churchill Hospital, Oxford

PE3 6DA

Peterborough Hospitals Trust, Peterborough

BH15 2JB

Dorset Cancer Centre, Poole Dorset

PO3 6AD

Portsmouth Oncology Centre at Saint Mary's Hospital, Portsmouth Hants

TN37 7RD

Conquest Hospital, Saint Leonards-on-Sea

SP2 8BJ

Salisbury District Hospital, Salisbury

S10 2SJ

Cancer Research Centre at Weston Park Hospital, Sheffield

SL2 4HL

Wexham Park Hospital, Slough, Berkshire

SM2 5PT

Royal Marsden - Surrey, Sutton

TQ2 7AA

Torbay Hospital, Torquay Devon

TR1 3LJ

Royal Cornwall Hospital, Truro, Cornwall

BN11 2DH

Worthing Hospital, Worthing

BA21 4AT

Yeovil District Hospital, Yeovil

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

G11 6NT

Beatson West of Scotland Cancer Centre, Glasgow

LL 18 5UJ

Glan Clwyd Hospital, Rhyl, Denbighshire

LL13 7TD

Wrexham Maelor Hospital, Wrexham

All Listed Sponsors
lead

Royal Liverpool University Hospital

OTHER_GOV

NCT00425360 - Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | Biotech Hunter | Biotech Hunter